All Mark T. Gladwin articles
-
NewsVaccine development program aims to prevent sepsis in newborns
Researchers have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants.
-
NewsResearchers identify new genetic risk factors for persistent HPV infections
A new finding suggests that certain women may have a genetic susceptibility for persistent or frequent HPV infections, potentially raising their risk of getting cervical cancer from a high-risk HPV infection.
-
NewsSingle dose typhoid conjugate vaccine (TCV) provides lasting efficacy in children
A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study.
